[DNLI] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -150.29%
YoY- -64.68%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 4,672 13,604 4,197 4,205 125,676 1,195 1,648 99.92%
PBT -53,950 -46,373 -58,650 -38,992 77,533 -35,371 -54,724 -0.94%
Tax 75 -113 -313 0 -2,379 0 0 -
NP -54,025 -46,260 -58,337 -38,992 77,533 -35,371 -54,724 -0.85%
Tax Rate - - - - 3.07% - - -
Total Cost 58,697 59,864 62,534 43,197 48,143 36,566 56,372 2.72%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,156.36 -340.05 -1,389.97 -927.28 61.69 -2,959.92 -3,320.63 -50.40%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.57 -0.48 -0.61 -0.41 0.82 -0.38 -0.59 -2.26%
EPS Diluted -0.56 -0.48 -0.61 -0.41 0.79 -0.38 -0.59 -3.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.